MAPT and Alzheimer disease: Although substantial evidence suggests that Aβ aggregation initiates the pathogenesis of AD, such as by driving tau protein aggregation and diffusion, tau aggregation appears to promote neurodegenerative lesions (Simic et al., 2016; Figure 2).